DCPH - Deciphera Pharmaceuticals EPS beats by $0.17 beats on revenue August, 04 2020 04:26 PM Deciphera Pharmaceuticals Inc. Deciphera Pharmaceuticals (NASDAQ:DCPH): Q2 GAAP EPS of -$1.20 beats by $0.17.More news on: Deciphera Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...